These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25841229)

  • 1. A model for treating HCV hepatitis in patients receiving methadone maintenance therapy.
    Malnick S; Sheidvasser V; Basevitz A; Levit S
    Isr J Psychiatry Relat Sci; 2014; 51(4):303-5. PubMed ID: 25841229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance.
    Mauss S; Berger F; Goelz J; Jacob B; Schmutz G
    Hepatology; 2004 Jul; 40(1):120-4. PubMed ID: 15239094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing a modified directly observed therapy intervention for hepatitis C treatment in a methadone maintenance program: implications for program replication.
    Bruce RD; Eiserman J; Acosta A; Gote C; Lim JK; Altice FL
    Am J Drug Alcohol Abuse; 2012 May; 38(3):206-12. PubMed ID: 22242700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hepatitis C infection for current or former substance abusers in a community setting.
    John-Baptiste A; Varenbut M; Lingley M; Nedd-Roderique T; Teplin D; Tomlinson G; Daiter J; Krahn M
    J Viral Hepat; 2009 Aug; 16(8):557-67. PubMed ID: 19243498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid virological response tailors the duration of treatment in hepatitis C virus genotype 3 patients treated with pegylated interferon alfa-2a and ribavirin in Pakistan.
    Gill U; Aziz H; Gill ML
    Int J Infect Dis; 2013 Nov; 17(11):e1017-21. PubMed ID: 23896656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peginterferon plus Ribavirin for chronic hepatitis C in opiate addicts on methadone/buprenorphine maintenance therapy.
    Belfiori B; Ciliegi P; Chiodera A; Bacosi D; Tosti A; Baldelli F; Francisci D
    Dig Liver Dis; 2009 Apr; 41(4):303-7. PubMed ID: 18938116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of chronic hepatitis C virus infection in severely opioid-dependent patients under heroin maintenance.
    Schulte B; Schütt S; Brack J; Isernhagen K; Deibler P; Dilg C; Verthein U; Haasen C; Reimer J
    Drug Alcohol Depend; 2010 Jun; 109(1-3):248-51. PubMed ID: 20167441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance.
    Martinez AD; Dimova R; Marks KM; Beeder AB; Zeremski M; Kreek MJ; Talal AH
    J Viral Hepat; 2012 Jan; 19(1):47-54. PubMed ID: 21129131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The politics of place(ment): problematising the provision of hepatitis C treatment within opiate substitution clinics.
    Rance J; Newland J; Hopwood M; Treloar C
    Soc Sci Med; 2012 Jan; 74(2):245-53. PubMed ID: 22133583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin.
    Waizmann M; Ackermann G
    J Subst Abuse Treat; 2010 Jun; 38(4):338-45. PubMed ID: 20362408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study.
    Grebely J; Petoumenos K; Matthews GV; Haber P; Marks P; Lloyd AR; Kaldor JM; Dore GJ; Hellard M;
    Drug Alcohol Depend; 2010 Mar; 107(2-3):244-9. PubMed ID: 19926405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C knowledge and alcohol consumption among patients receiving methadone maintenance treatment in Shanghai, China.
    Du J; Wang Z; Xie B; Zhao M
    Am J Drug Alcohol Abuse; 2012 May; 38(3):228-32. PubMed ID: 22242740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.
    Liu CJ; Chuang WL; Lee CM; Yu ML; Lu SN; Wu SS; Liao LY; Chen CL; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Liu CH; Su WW; Lin CL; Jeng YM; Chen PJ; Chen DS
    Gastroenterology; 2009 Feb; 136(2):496-504.e3. PubMed ID: 19084016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus Management in Opioid Use Disorder Patients on Methadone.
    Talal AH; Andrews P; Mcleod A; Chen Y; Sylvester C; Markatou M; Brown LS
    Clin Infect Dis; 2019 Jul; 69(2):323-331. PubMed ID: 30329042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of pegylated interferon alfa-2a or alfa-2b in combination with ribavirin in the treatment of chronic hepatitis caused by hepatitis C virus genotype 1b.
    Mach TH; Cieśla A; Warunek W; Janas-Skulina U; Cibor D; Owczarek D; Ciećko-Michalska I
    Pol Arch Med Wewn; 2011 Dec; 121(12):434-9. PubMed ID: 22157768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acute HCV infection in HIV-positive patients: experience from a multicentre European cohort.
    Vogel M; Dominguez S; Bhagani S; Azwa A; Page E; Guiguet M; Valantin MA; Katlama C; Rockstroh JK; Nelson M
    Antivir Ther; 2010; 15(2):267-79. PubMed ID: 20386082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retention rate and side effects in a prospective trial on hepatitis C treatment with pegylated interferon alpha-2a and ribavirin in opioid-dependent patients.
    Ebner N; Wanner C; Winklbaur B; Matzenauer C; Jachmann CA; Thau K; Fischer G
    Addict Biol; 2009 Apr; 14(2):227-37. PubMed ID: 19291011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and safety of pegylated-interferon plus ribavirin in HIV-infected patients co-infected with hepatitis C virus in clinical practice: a 32 cases observational follow-up].
    Seydi M; Morlat P; Bonnet F; Rambeloarisoa J; Bernard N; Lacoste D; Bonarek M; Trimoulet P; Ramanampamonjy R; Lafon ME; Dramé M; Beylot J
    Rev Med Interne; 2005 Apr; 26(4):280-7. PubMed ID: 15820563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low risk for hepatitis C seroconversion in methadone maintenance treatment.
    Peles E; Schreiber S; Rados V; Adelson M
    J Addict Med; 2011 Sep; 5(3):214-20. PubMed ID: 21844836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid substitutions in the hepatitis C virus core region of genotype 1b affect very early viral dynamics during treatment with telaprevir, peginterferon, and ribavirin.
    Akuta N; Suzuki F; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2010 Apr; 82(4):575-82. PubMed ID: 20166188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.